<code id='B357AC4C74'></code><style id='B357AC4C74'></style>
    • <acronym id='B357AC4C74'></acronym>
      <center id='B357AC4C74'><center id='B357AC4C74'><tfoot id='B357AC4C74'></tfoot></center><abbr id='B357AC4C74'><dir id='B357AC4C74'><tfoot id='B357AC4C74'></tfoot><noframes id='B357AC4C74'>

    • <optgroup id='B357AC4C74'><strike id='B357AC4C74'><sup id='B357AC4C74'></sup></strike><code id='B357AC4C74'></code></optgroup>
        1. <b id='B357AC4C74'><label id='B357AC4C74'><select id='B357AC4C74'><dt id='B357AC4C74'><span id='B357AC4C74'></span></dt></select></label></b><u id='B357AC4C74'></u>
          <i id='B357AC4C74'><strike id='B357AC4C74'><tt id='B357AC4C74'><pre id='B357AC4C74'></pre></tt></strike></i>

          entertainment

          entertainment

          author:entertainment    Page View:76556

          The Senate has set its eyes on regulating insurance plans for some of the most vulnerable patients in the U.S. — the 12.5 million people eligible for both Medicare and Medicaid.

          “They’re a complex group of people with a lot of chronic conditions — mental illness, frailty, disability,” said Jose Figueroa, an internal medicine physician and health policy expert at Brigham and Women’s Hospital. Over a third of these dual-eligible beneficiaries have less than a high school education, and about 90% make less than $20,000 per year.

          advertisement

          Just around 15% of beneficiaries are eligible for both Medicare and Medicaid, but they account for a third of these programs’ spending — around $440 billion — and still don’t receive better health care, Sen. Bill Cassidy (R-La.) pointed out in a JAMA viewpoint published earlier this month. “The root cause of worse outcomes despite spending more money is a lack of coordination of care,” Cassidy wrote.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic
          Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

          AdobeTheFoodandDrugAdministrationhasclearedOtsukaPharmaceutical’sdigitaltreatmentformajordepressived

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          Gut bacteria may contribute to kidney autoimmunity, study finds

          AdobeRightnow,insideyourdigestivetract,therearetrillionsofbacteria,fungi,andvirusesthatformatinyuniv